Company intelligence
Neuland Laboratories Limited
Your Trusted CDMO partner from Lab to Commercial
About Neuland Laboratories Limited
Founded in 1984, Neuland Labs is a globally recognised Contract Development and Manufacturing Organization (CDMO), offering comprehensive customised NCE development services. Our team comprises highly skilled scientists, engineers, and technicians who utilise their expertise and advanced technologies to address the complex and evolving requirements of our clients. We collaborate with pharmaceutical and biotechnology companies to support all aspects of their chemistry needs, ranging from early development stages to commercial manufacturing, including process development, optimisation, analytical testing, and regulatory compliance. Neuland Labs possesses the capabilities and flexibility to manage both single-step processes and complete synthesis, handling projects from lab to commercial supply. We provide quantities suitable for clinical trials as well as full commercial-scale production of new chemical entities (NCEs), key starting materials (KSMs), active pharmaceutical ingredients (APIs), and their intermediates, ensuring efficient tech transfer timelines.
Verified activity
Signals from Neuland Laboratories Limited
5 published signals
Research & Knowledge
Neuland Laboratories Limited released Linezolid as a first-in-class oxazolidinone antibiotic with broad clinical utility against Gram-positive bacterial infections.
Reported by Neuland Laboratories Limited
Research & Knowledge
Neuland Laboratories Limited published an article examining why impurity profiling has become a strategic component of peptide development and how advanced analytical approaches are helping address these challenges.
Reported by Neuland Laboratories Limited
Presence & Recognition
Neuland Laboratories Limited is attending BioChem Outsourcing 2026 in Boston from September 15-17, 2026, to explore flexible development and manufacturing solutions for pharmaceutical and biotechnology innovators.
Reported by Neuland Laboratories Limited
Presence & Recognition
Neuland Laboratories Limited hosted the NMDC Hyderabad Marathon 2026 over August 29-30, bringing together colleagues from across the organization.
Reported by Neuland Laboratories Limited
Research & Knowledge
Neuland Laboratories Limited published a molecule Monday featuring Levofloxacin Hemihydrate, a broad-spectrum fluoroquinolone antibiotic with antimicrobial coverage and bioavailability.
Reported by Neuland Laboratories Limited